Acceleration of Clinical Timelines Using Azzur Cleanrooms on Demand™, a Novel Approach to Biopharmaceutical Manufacturing

  • Current industry challenges and opportunities related to biopharma manufacturing
  • Internal manufacturing capability establishment challenges for biopharma
  • Challenges related to outsourcing of technology and process throughout product lifecycle
  • The Azzur Cleanrooms on Demand™ model
  • Case Studies

Ravi Samavedam
Chief Innovation Officer
Azzur Group

Ravi Samavedam is a Biochemical Engineer with more than 20 years of experience in the pharmaceutical and biotechnology industries. Ravi joined Azzur in 2012, and prior to his appointment as CINO of Azzur Group, Ravi was the President and COO of Azzur Cleanrooms on Demand™ and previously served as  General Manager of the Boston-area consulting practice.  Prior to Azzur, Ravi has been part of the technical operations and quality/validation departments at Baxter, Amgen, and Shire.

Ravi is an expert in phase-appropriate cGMP implementation, process validation, supplier management, and technology transfer. Azzur Cleanrooms on Demand™ offers flexible early-phase cGMP manufacturing options designed to mitigate risk and increase speed to clinic. In addition to his work with Azzur, Ravi is an active member of industry and peer groups, and he is a frequent speaker at industry events.

From Discovery to Delivery™, Azzur Group provides the life science community full life-cycle solutions for all their GxP needs. From Azzur Cleanrooms on Demand™ facilities, to our labs, training centers and consulting offices across the nation, Azzur Group helps organizations start, scale, and sustain their growing enterprises. With nearly four decades of service to the life science community, we have become a trusted partner to the world’s leading pharmaceutical, biotechnology, medical device, and healthcare companies, as well as their supply chain. Follow us on LinkedIn. For more information, visit